Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04113759 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction Following Hip Arthroscopy
A NA study of Femoral Acetabular Impingement and Labral Tear, Glenoid, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT04113759: Recruiting NA study of Femoral Acetabular Impingement and Labral Tear, Glenoid, sponsored by Rush University Medical Center.
NCT04113759 is a NA study of Femoral Acetabular Impingement and Labral Tear, Glenoid that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04113759, a NA study of Femoral Acetabular Impingement and Labral Tear, Glenoid, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and/or labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will take place at 1-month, 3-months, 6-months, and 1-year.
Primary Outcome
Will be measured with dynamometer
Conditions Studied
Interventions
- BEHAVIORAL Blood Flow Restriction Rehabilitative Therapy
- BEHAVIORAL Sham BFR Rehabilitative Therapy
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT04113759 shows while recruiting
NCT04113759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Femoral Acetabular Impingement appearing as the primary indexed condition, and to 2 interventions - of which Blood Flow Restriction Rehabilitative Therapy is the first listed.
NCT04113759 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04113759 about?
NCT04113759 is a clinical study titled "Blood Flow Restriction Following Hip Arthroscopy". This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and/or labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will ...
What is the current status of trial NCT04113759?
This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2023-08-01. Estimated completion is 2028-01.
What conditions does trial NCT04113759 study?
This clinical trial studies the following conditions: Femoral Acetabular Impingement, Labral Tear, Glenoid.
What interventions are being tested in trial NCT04113759?
The interventions under investigation include: Blood Flow Restriction Rehabilitative Therapy (BEHAVIORAL), Sham BFR Rehabilitative Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04113759?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04113759 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoral Acetabular Impingement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04113759's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI